Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiac structure and function in renal disease

K Amann1, E Ritz

  • 1Department of Pathology, University of Heidelberg, Germany.

Current Opinion in Nephrology and Hypertension
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

De novo glomerulonephritis in patients during remission from Wegener's granulomatosis.

Clinical nephrology·1992
Same author

Reduced capillary density in the myocardium of uremic rats--a stereological study.

Kidney international·1992
Same author

Renal histology in polycystic kidney disease with incipient and advanced renal failure.

Kidney international·1992
Same author

The effect of uninephrectomy on progression of renal failure in autosomal dominant polycystic kidney disease.

Journal of the American Society of Nephrology : JASN·1992
Same author

Severe hemorrhagic complications from infection with nephropathia epidemica strain of Hantavirus.

Clinical nephrology·1992
Same author

Disturbed calcium metabolism in renal failure--pathogenesis and therapeutic strategies.

Kidney international. Supplement·1992
Same journal

Sex differences in renal acid-base regulation.

Current opinion in nephrology and hypertension·2026
Same journal

Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors.

Current opinion in nephrology and hypertension·2026
Same journal

Financial and policy challenges of delivering kidney replacement therapies in resource-limited settings.

Current opinion in nephrology and hypertension·2026
Same journal

The role of kir4.1/Kir5.1 in mediating the effect of angiotensin-II on Na-Cl-cotransporter.

Current opinion in nephrology and hypertension·2026
Same journal

Role of the calcium-sensing receptor in regulating calcium transport in the thick ascending limb.

Current opinion in nephrology and hypertension·2026
Same journal

Social determinants of chronic kidney disease: from association to clinical and population action.

Current opinion in nephrology and hypertension·2026
See all related articles

Uraemic patients often die from cardiac ischemia, even without coronary lesions. Structural heart abnormalities like left ventricular hypertrophy, fibrosis, and microvascular changes contribute to reduced ischemia tolerance in these patients.

Area of Science:

  • Cardiology
  • Nephrology
  • Pathology

Background:

  • Cardiac death is the leading cause of mortality in patients with kidney failure (uremia).
  • Ischemia-related cardiac events occur frequently in uremic patients, independent of significant coronary artery disease.

Purpose of the Study:

  • To review recent findings on cardiac structural abnormalities affecting ischemia tolerance in uremic patients.
  • To elucidate the mechanisms underlying cardiac death in the context of uremia.

Main Methods:

  • Review of current literature on cardiac structure and function in uremic patients.
  • Analysis of pathological findings related to cardiac ischemia and uremia.

Main Results:

  • Uremia is associated with left ventricular hypertrophy not solely due to hypertension.

Related Experiment Videos

  • Interstitial fibrosis is a common finding in the hearts of uremic patients.
  • Myocardial microvascular abnormalities, including capillary rarefaction and arteriolar wall thickening, are prevalent.

    • Conclusions:

    • Structural cardiac changes in uremia significantly impair the heart's ability to tolerate ischemia.
    • These abnormalities, including hypertrophy, fibrosis, and microvascular damage, contribute to the high incidence of cardiac death in uremic individuals.